ORIGINAL RESEARCH article

Front. Psychiatry

Sec. Schizophrenia

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1581756

This article is part of the Research TopicCognitive impairments in schizophrenia, bipolar disorder, and major depression: Dissecting common and divergent featuresView all 3 articles

Cognitive Impairment Across the Schizophrenia Spectrum: A Comparative Neuropsychological Study

Provisionally accepted
  • 1Wuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China
  • 2Wannan Medical College, Wuhu, Anhui Province, China
  • 3Guangdong Provincial People's Hospital, Guangzhou, Guangdong Province, China

The final, formatted version of the article will be published soon.

IntroductionCognitive impairment represents a core feature of schizophrenia spectrum disorders, predating psychosis onset and persisting throughout illness progression. This cross-sectional study systematically evaluates neurocognitive functioning across five critical populations: multi-episode chronic schizophrenia (MECS), first-episode psychosis (FEP), clinical high-risk (CHR) individuals, first-degree relatives (FDR), and healthy controls (HC).Methods A comprehensive neuropsychological battery was administered to 366 participants: 40 MECS, 94 FEP, 54 CHR, 80 FDR, and 98 HC. Assessments included: Processing speed: Trail Making Test-A (TMT-A), Digit Symbol Coding Test (DST). Attention: Continuous Performance Test (CPT). Verbal memory: Hopkins Verbal Learning Test-Revised (HVLT-R) .Visual memory: Brief Visuospatial Memory Test-Revised (BVMT-R) . Executive function: Stroop Color and Word Test (SCWT). Group differences were analyzed using Analysis of Covariance (covariates: age, education) with Bonferroni correction, supplemented by multinomial logistic regression.Results A stepwise gradient of impairment emerged across the schizophrenia spectrum (HC > FDR > CHR > FEP > MECS), with significant between-group differences (p<0.001) persisting after covariate adjustment. Key findings revealed: 1. MECS demonstrated cognitive deficits, showing significantly poorer verbal memory (HVLT-R:d=0.65:p<0.001) and executive function (Stroop words :d=0.56, p=0.003,Stroop color:d=0.60, p=0.006,Stroop words color:d=0.46, p=0.03) performance than FEP.2. CHR exhibited intermediate impairment: - Outperformed FEP in processing speed (TMT-A: d=0.45, p=0.009, DST: d=065, p=0.001), attention (CPT: d=0.42, p=0.03), and executive function (Stroop words color: d=0.39, p=0.03). - Underperformed FDR across all domains except visual memory (BVMT-R: d=0.16, p=0.92) .3. FDR showed subtle but consistent deficits relative to HC (all tests p<0.05), with largest effects in visual memory (BVMT-R: d=0.99, <0.001).Discussion These findings support a stratified continuum of cognitive impairment across schizophrenia progression. While chronic patients manifest generalized deficits, at-risk populations demonstrate distinct profiles: FDR display subclinical vulnerabilities, whereas CHR show intermediate impairment exceeding familial risk but preceding acute psychosis. The differential trajectory of verbal memory and executive function deficits from FEP to MECS suggests progressive deterioration in higher-order cognitive domains. These gradient patterns may inform stage-specific cognitive interventions across the schizophrenia spectrum.

Keywords: cognitive functions, multi-episode chronic schizophrenia, First-episode psychosis, Clinical high risk for psychosis, irst-degree relatives of patients with schizophrenia

Received: 23 Feb 2025; Accepted: 09 Apr 2025.

Copyright: © 2025 He, Wei, Huang, Wang, GUO and Hou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
LILI GUO, Wuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China
Cai-Lan Hou, Guangdong Provincial People's Hospital, Guangzhou, 510317, Guangdong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.